• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Paltown

Paltown

  • About Us ▼
    • About Us
    • Board of Directors
    • Staff
    • Community Leaders
    • Our Inspiration
    • Financials & Annual Report
    • Partners and Sponsors
  • Communities ▼
    • Communities
    • COLONTOWN University
  • Training ▼
    • Training
    • Clinical Trials Training
    • Empowered Patient Leaders
  • In the News ▼
    • In the News
      • News Archive
    • Press Releases
    • Blog
  • Donate

brain trust

October 16, 2018

Chelsea Boet, MD

Dr. Chelsea Boet is a primary care physician board certified in Internal Medicine and Pediatrics. She cares for patients from birth through end of life, specializing in preventative care and management of chronic medical illnesses. Special interests include breastfeeding medicine. Dr. Boet earned her BA from Kalamazoo College, and completed her MD training at Wayne State University School of Medicine.… Read more

September 30, 2018

Chris Heery, MD

Dr. Christopher Heery is the Chief Medical Officer for Bavarian Nordic where he oversees the clinical development of BN’s pipeline, comprising therapeutic cancer vaccines and vaccines for prevention of infectious diseases. He is a medical oncologist by training. He trained at the National Cancer Institute in the Laboratory of Tumor Immunology and Biology, where he went on to be the Head of the Clinical Trials group in that translational ImmunoOncology-focused branch.… Read more

March 14, 2018

Chris Yoo, Ph.D.

Chris Yoo, Ph.D.

Chris has over 20 years of experience in advancing cutting-edge biomedical information technology. He is Founder, President & CEO of Systems Imagination, Inc., which offers advanced cognitive computing technology and artificial intelligence methodologies to translate big data into valuable insights. Chris was instrumental at IBM as Head of Strategy and Planning in the Information Based Medicine group, where he developed initiatives to target the growing field of personalized medicine as new molecular therapeutics were first being used to treat cancer.… Read more

December 17, 2017

Kamala Maddali, DVM, Ph.D.

Kamala Maddali, DVM, Ph.D.

Vice President, Biopharma Collaborations & Companion Diagnostics, Cancer Genetics

Dr. Maddali’s mantra for leadership is to “spread some sunshine” by being passionate and positive about her commitment to patient’s health via novel testing solutions for precision medicine.

While at Merck, Dr. Maddali played a pivotal role as a biomarker scientist understanding the various pharmacological and toxic effects of investigational drugs across multiple therapeutic areas in oncology, neurology and obesity disorders. … Read more

September 8, 2017

Dr. Scott Kopetz

Scott Kopetz, M.D., Ph.D., Associate Professor, GI Medical Oncology, University of Texas MD Anderson Cancer Center
Dr. Scott Kopetz graduated Summa Cum Laude from Vanderbilt University with a bachelor’s degree in Biomedical Engineering/Electrical and received his medical degree from Johns Hopkins School of Medicine. He obtained his residency training in Internal Medicine at Duke University Medical Center, followed by a medical oncology fellowship at MD Anderson Cancer Center.… Read more

August 28, 2017

Dr. Christopher Lieu

Director, Gastrointestinal Medical Oncology, University of Colorado School of Medicine

Deputy Associate Director for Clinical Research, University of Colorado School of Medicine

Dr. Lieu joined the University of Colorado School of Medicine faculty as an Assistant Professor of Medicine in July 2011.  He trained in internal medicine at the University of Colorado, where he also served as a Chief Medical Resident.  … Read more

August 28, 2017

Stephen Schoenberger, Ph.D.

Professor, Laboratory of Cellular Immunology
La Jolla Institute for Allergy and Immunology
Director of Translational Science, San Diego Center for Cancer
Immunotherapy
Head of Cancer Vaccines, Human Longevity, Inc

Dr. Schoenberger is a Professor in the Laboratory of Cellular Immunology and Co-Director of the San Diego Center for Personalized Cancer Immunotherapy, as well as Adjunct Professor of Medicine in the Division of Hematology and Oncology at the UCSD Moores Cancer Center.… Read more

Connect with Us

Visit our Communities

The PALTOWN Development Foundation is a 501(c)3 corporation. EIN: 81-4532089

Donate today!

Footer

PALTOWN Development Foundation
969 Diggs Rd., Crownsville, MD, 21032
EIN: 81-4532089
410.881.3160
contact(at)paltown.org

Our policies:

Privacy Policy

Terms of Use Policy

Copyright © 2023 · PALTOWN